LeMaitre Vascular Inc

Healthcare · Medical Instruments & Supplies

79.50$ -1.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

LeMaitre Vascular Inc (LMAT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 250 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LMAT
Line item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	71	78	89	101	106	117	129	154	162	193	220	250
Cost of Revenue	23	24	26	30	32	37	45	53	57	66	69	71
Gross Profit	48	54	63	71	74	80	85	101	105	127	151	179
Research & Development	4.7	5.5	6.1	6.6	8.2	9.3	10	12	13	17	16	14
Selling, General & Administrative	14	14	14	17	18	19	23	26	29	32	36	42
Total Operating Expenses	41	43	47	50	53	59	56	65	78	90	99	111
Operating Income	6.3	12	16	21	28	21	29	36	27	37	52	68
Interest Expense	0.0	0.0	0.0	0.0	0.0	5.9	1.3	2.2	1.0	0.0	0.2	5.2
Pre-Tax Income	6.3	11	16	21	28	22	27	34	27	39	57	75
Income Tax Expense	2.4	3.7	5.7	3.9	5.5	3.7	6.1	7.4	6.9	9.4	13	17
Net Income	3.9	7.8	11	17	23	18	21	27	21	30	44	58
EBITDA	9.7	15	20	25	33	27	37	46	37	49	67	91

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings